Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dengue Shock Syndrome
|
9 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||
Gastric Cardia Adenocarcinoma
|
11 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.020 | 1.000 | 2 | 2011 | 2011 | ||||
Extrapulmonary Small Cell Carcinoma
|
11 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant Squamous Cell Neoplasm
|
12 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Gastric Cardia Carcinoma
|
13 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Oral Cavity Carcinoma
|
16 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Gastritis
|
21 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Familial multiple trichoepitheliomata
|
32 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Human papilloma virus infection
|
42 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Malignant neoplasm of gastrointestinal tract
|
55 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Gallbladder Carcinoma
|
75 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Giant Cell Arteritis
|
78 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.020 | 1.000 | 2 | 2011 | 2011 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Head and Neck Carcinoma
|
118 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||
Adenocarcinoma
|
168 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of mouth
|
184 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant neoplasm of esophagus
|
214 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.800 | 0.929 | 14 | 2011 | 2019 | ||||
Gastric Adenocarcinoma
|
235 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Squamous cell carcinoma
|
257 | 0.620 | 0.400 | 10 | 94306584 | missense variant | A/G | snv | 0.28 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2013 |